Slingshot Biosciences

Emeryville, CA · Founded 2012 · Privately Held (backing)

Developer of engineered synthetic cells designed to speed up complex drug research. Slingshot Biosciences is based in Emeryville, CA and was founded in 2012. It was valued at $138 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $49.8 million across 2 recorded rounds; the latest was a $26.2 million early-stage round in Jan 2023.

PMV mark · valuation
$138.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$49.8M
Last round
Early Stage VC
Jan 2023

Who backs Slingshot Biosciences?

7 investors
InvestorType
Impact AssetsOther
ARCH Venture PartnersVenture capital
Anterra Capital—
Jeffrey Kim—
Northpond Ventures—
QB3—
William Hyun—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Slingshot Biosciences investors

7 investors are on record for Slingshot Biosciences, including Impact Assets, ARCH Venture Partners, Anterra Capital and Jeffrey Kim. The early-stage round in Jan 2023 drew 10 investors.

Free account
More of Slingshot Biosciences with a free account
  • ·Watch Slingshot Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Slingshot Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View